GF-1011

N/A

Report date: 2024/12/02 13:50:04
NME

Base Information

Drug NameGF-1011
Drug Alias NameGF-1011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGenfleet Therapeutics (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenfleet Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A